This Week in Psychedelics - 4.3.20

ThisWeekinPsychedelics.png

Cannabis

  • New York drops legalization from budget, likely ending 2020 push (Leafly)

  • Lack of protective gear at cannabis labs could threaten weed supply (The London Free Press)

  • Scientists Sue DEA Over Alleged ‘Secret’ Document That Delayed Marijuana Research Expansion (Marijuana Moment)

  • Idaho Activists Suspend Campaign To Legalize Medical Marijuana Due To Coronavirus (Marijuana Moment)

  • Boise startup reworks CBD and THC testing technology to test for COVID-19 in minutes (KTVB)

  • Missouri Marijuana Legalization Campaign In Jeopardy Due To Coronavirus (Marijuana Moment)

  • Cannabis users, shops suffer high anxiety after Massachusetts shuts down recreational sales (NBC News)

  • FDA Warns Former NFL Player To Stop Claiming CBD Can Cure Coronavirus (Marijuana Moment)

  • More Than 90% of Legal Marijuana Products Too Strong for Chronic Pain Relief (SciTechDaily)

  • Virginia Groups Push Governor To Amend Marijuana Decriminalization Bill On His Desk (Marijuana Moment)

  • Cannabis Scientists Are Chasing the Perfect High (The New York Times)

  • Senate Housing Bill Would Prevent Evictions For State-Legal Marijuana Extraction (Marijuana Moment)

  • Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent (NORML)

  • Large international study finds cannabis use is linked to lower physical activity levels in adolescents (PsyPost)

  • Cannabis license application deadline extended due to COVID-19 pandemic (WLS-TV)

  • Study sheds light on common adverse reactions to cannabis (News Medical)

  • How cannabis and humans evolved together (Leafly)

  • Teen Weed Smokers May Have Trouble Falling Asleep as Adults, New Study Says (MERRY JANE)

  • New Medicinal Cannabis Rules Launch in New Zealand (The Cannabis Exchange)

  • Washington Governor Signs Bill To Diversify State’s Marijuana Industry (Marijuana Moment)

  • Study indicates vaporized cannabis creates drug-seeking behavior (Brinkwire)

  • Feds Funding Research On How Marijuana Consumers Are Impacted By Coronavirus (Marijuana Moment)

  • Arbitrary & excessive: Marijuana trafficking sentences in Alabama (Southern Poverty Law Center)

LSD

  • This New York City Pharma Startup Wants To Turn LSD Into An FDA-Approved Medicine For Anxiety Disorder (Forbes)

  • MindMed Acquires Exclusive License to Eight Clinical Trials of LSD, Partners with World-Leading Psychedelic Research Laboratory at University Hospital Basel (Yahoo! Finance)

  • From Aldous Huxley to the Beatles: how LSD has inspired art (The Guardian)

Magic Mushrooms

  • Psilocybin Mindfulness Negatively Correlated with 5-HT2A Binding, Study Finds (Psychedelic Science Review)

  • Champignon Brands To Acquire Psilocybin Research Firm Tassili Life Sciences (The Deep Dive)

  • As Health-Conscious Consumers Seek Fresh Nutritional Avenues, Artisanal Mushrooms Step Into the Light (PR Newswire)

  • Psilocybin Kitchen: The Basics of Cooking with Mushrooms (DoubleBlind)

  • Understanding the Buzz About Magic Mushrooms (Psychology Today)

MDMA

Ayahuasca

  • Drinking Ayahuasca Without DMT is Powerful and Traditional (Kahpi)

Peyote

  • Why are some Native Americans fighting efforts to decriminalize peyote? (Los Angeles Times)

Iboga

  • Clear Sky Recovery Featured in the Documentary Ibogaine: Cure for a Crisis (PRWeb)

  • How psychedelic medicine is being used in the fight to end opioid addiction (EPM Magazine)

Ketamine

Miscellaneous

  • Coronavirus Upends Marijuana, Psychedelics And Drug Reform Ballot Measures (Forbes)

  • A New Breed of Drug Dealer Has Turned Buying Drugs into a Treasure Hunt (VICE)

  • DC Activists Have A New Plan To Get Psychedelics Decriminalization On The Ballot Despite Coronavirus (Marijuana Moment)

  • People with low psychological well-being more likely to report positive outcomes after psychedelic use (PsyPost)

  • Coronavirus, Drugs, and the Future of Festivals (DanceSafe)

  • Understanding Drug Potency and Its Importance in Psychedelic Research (Psychedelic Science Review)

  • Ehave, Inc. Appoints Dr. Mark Braunstein as Chief Psychedelic Officer (Yahoo! Finance)

  • Comparing Aeruginascin and Bufotenidine (Psychedelic Science Review)

  • Ease rules on research into psychedelic drugs, urges David Nutt (The Guardian)

  • An Insight into Drug Testing Facilities in the Netherlands (Volteface)

  • The Structure and Function of the Serotonin 5-HT2B Receptor (Psychedelic Science Review)

  • Ex-Cheerleader Jackee Stang Just Launched the ‘Goop of Psychedelics’ (The Daily Beast)

  • Can psychedelic therapy reduce the mental health impacts of the coronavirus pandemic? (The Sacramento Bee)

  • Revisiting the potential of using psychedelic drugs in psychiatry (Medical Xpress)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.